The study noted that patients in central and eastern Europe experienced more severe bronchiectasis and higher rates of exacerbations leading to hospitalizations compared to other regions[2].

Macrolide maintenance therapy in patients with bronchiectasis significantly reduces the risk for major adverse cardiovascular events.

including diagnostic criteria and management of acute exacerbation of CB (AECB) in the elderly patient.

The phase 3 trial achieved a statistically significant reduction in the frequency of exacerbations in patients with bronchiectasis, a serious, chronic lung disease with no approved treatment that ...

Permanent changes such as bronchiectasis may persist ... with moderate doses of inhaled corticosteroids and has had two exacerbations over the past 3 years requiring oral steroids Case 3: A ...

The study measured the drop in the rate of pulmonary exacerbations, events in which lung function drops sharply and patients ...